These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29498199)

  • 1. β-2 Agonists as Misusing Drugs? Assessment of both Clenbuterol- and Salbutamol-related European Medicines Agency Pharmacovigilance Database Reports.
    Milano G; Chiappini S; Mattioli F; Martelli A; Schifano F
    Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):182-187. PubMed ID: 29498199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions.
    Schifano F; Chiappini S; Corkery JM; Guirguis A
    Int J Neuropsychopharmacol; 2019 Apr; 22(4):270-277. PubMed ID: 30722037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports.
    Schifano F; Chiappini S
    PLoS One; 2018; 13(10):e0204443. PubMed ID: 30286103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is There a Potential of Misuse for Quetiapine?: Literature Review and Analysis of the European Medicines Agency/European Medicines Agency Adverse Drug Reactions' Database.
    Chiappini S; Schifano F
    J Clin Psychopharmacol; 2018 Feb; 38(1):72-79. PubMed ID: 29210868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the 2004-2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems.
    Schifano F; Chiappini S; Corkery JM; Guirguis A
    Front Pharmacol; 2019; 10():46. PubMed ID: 30774595
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS).
    Chiappini S; Vickers-Smith R; Guirguis A; Corkery JM; Martinotti G; Harris DR; Schifano F
    Pharmaceuticals (Basel); 2022 May; 15(6):. PubMed ID: 35745593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is There a Potential of Misuse for Venlafaxine and Bupropion?
    Schifano F; Chiappini S
    Front Pharmacol; 2018; 9():239. PubMed ID: 29618978
    [No Abstract]   [Full Text] [Related]  

  • 8. Signal detection activity on EudraVigilance data: analysis of the procedure and findings from an Italian Regional Centre for Pharmacovigilance.
    Monaco L; Melis M; Biagi C; Donati M; Sapigni E; Vaccheri A; Motola D
    Expert Opin Drug Saf; 2017 Mar; 16(3):271-275. PubMed ID: 28094583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A descriptive study of adverse events from clenbuterol misuse and abuse for weight loss and bodybuilding.
    Spiller HA; James KJ; Scholzen S; Borys DJ
    Subst Abus; 2013; 34(3):306-12. PubMed ID: 23844963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports.
    Chiappini S; Schifano F; Corkery JM; Guirguis A
    J Psychopharmacol; 2021 Jun; 35(6):681-692. PubMed ID: 33427017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases.
    Chiappini S; Vickers-Smith R; Guirguis A; Corkery JM; Martinotti G; Schifano F
    Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database.
    Chiappini S; Schifano F; Corkery JM; Guirguis A
    Brain Sci; 2020 Feb; 10(2):. PubMed ID: 32079135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.
    Auffret M; Labreuche J; Duhamel A; Deheul S; Cottencin O; Bordet R; Gautier S; Rolland B
    Drug Saf; 2017 Mar; 40(3):257-262. PubMed ID: 27988884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of main urinary metabolites of β2-agonists clenbuterol, salbutamol and terbutaline by liquid chromatography high resolution mass spectrometry.
    Domínguez-Romero JC; García-Reyes JF; Martínez-Romero R; Martínez-Lara E; Del Moral-Leal ML; Molina-Díaz A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 923-924():128-35. PubMed ID: 23500357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographical variation in reporting Interstitial Lung Disease as an adverse drug reaction: findings from an European Medicines Agency analysis of reports in EudraVigilance.
    Pinheiro L; Blake K; Januskiene J; Yue QY; Arlett P
    Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):705-12. PubMed ID: 27004571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction.
    Baronti A; Grieco A; Vibelli C
    Eur J Respir Dis; 1980 Jun; 61(3):143-50. PubMed ID: 7002574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clenbuterol and salbutamol in the symptomatic treatment of patients with reversible airways obstruction.
    Jaffé G; Grimshaw JJ
    Pharmatherapeutica; 1983; 3(7):492-5. PubMed ID: 6366806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial.
    Pasotti C; Capra A; Vibelli C
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):176-80. PubMed ID: 376459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An algorithm to detect unexpected increases in frequency of reports of adverse events in EudraVigilance.
    Pinheiro LC; Candore G; Zaccaria C; Slattery J; Arlett P
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):38-45. PubMed ID: 29143393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity From Unintentional Pediatric Ingestion of a Performance-Enhancing Drug: A Case Report With Review of Clenbuterol Toxicity and Treatment.
    Bonney CF; Hatten B; Wang GS
    J Emerg Med; 2019 Oct; 57(4):e105-e108. PubMed ID: 31493966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.